PeterSpornMDFCCP, ATSF
Pulmonology • Chicago, ILCritical Care Medicine, Interstitial Lung Diseases
Professor of Medicine, Cell and Developmental Biology, and Medical Education, Feinberg School of Medicine, Northwestern University
Dr. Sporn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Northwestern University Feinberg School of Medicine
303 E. Superior St., SQBRC 5-302
Chicago, IL 60611Phone+1 312-908-8163Fax+1 312-503-0411
Education & Training
University of MichiganFellowship, Pulmonary Disease and Critical Care Medicine, 1984 - 1987
Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Allergy and Immunology, 1983 - 1984
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1980 - 1983
Wayne State University School of MedicineClass of 1980
Certifications & Licensure
IL State Medical License 1991 - 2026
MI State Medical License 1985 - 1992- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Member, Pulmonary Disease Board American Board of Internal Medicine
- Regional Top Doctor Castle Connolly, 2005-2021
- Chair, Pulmonary Disease Exam Writing Committee American Board of Internal Medicine
- Join now to see all
Clinical Trials
- Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension Start of enrollment: 2008 Nov 01
- Study of Intravenous ATYR1923 (Efzofitimod) for Pulmonary Sarcoidosis Start of enrollment: 2019 Jan 29
- Routine Cardiac Screening in Sarcoidosis Patients Start of enrollment: 2019 Apr 05
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsMyeloid Zfhx3 deficiency protects against hypercapnia-induced suppression of host defense against influenza A virus.S Marina Casalino-Matsuda, Fei Chen, Francisco J Gonzalez-Gonzalez, Hiroaki Matsuda, Aisha Nair
JCI Insight. 2024-01-16 - 18 citationsEfzofitimod for the Treatment of Pulmonary Sarcoidosis.Daniel A Culver, Shambhu Aryal, Joseph Barney, Connie C W Hsia, W Ennis James
Chest. 2023-04-01 - 1 citationsA Novel MIP-1-Expressing Macrophage Subtype in BAL Fluid from Healthy Volunteers.Paul A Reyfman, Elizabeth S Malsin, Basil Khuder, Nikita Joshi, Gaurav Gadhvi
American Journal of Respiratory Cell and Molecular Biology. 2023-02-01
Press Mentions
FSR Expands Scientific Advisory Board to Improve Research, CareSeptember 10th, 2024
Grant Support
- Clinical Studies NetworkFoundation for Sarcoidosis Research2018–2022
- Hypercapnia and Suppression of Antiviral Host DefenseNational Institutes of Health2017–2020
- Hypercapnia and Suppression of Antiviral Host DefenseNational Institutes of Health2016–2017
Committees
- Program Committee, Asthma, Allergy and Inflammation Assembly 2021 - Present
- Member, ABIM Pulmonary Disease Board 2020 - Present
- Chair, ABIM Pulmonary Disease Board Examination Writing Committee 2018 - Present
- Member, American Thoracic Society Scientific Advisory Committee 2018 - Present
- Member, Veterans Affairs Pulmonary Grant Review Panel 2018 - Present
- Member, ABIM Pulmonary Disease Board Examination Writing Committee 2010 - 2018
Professional Memberships
- Member
- World Association of Sarcoidosis and Other Granulomatous DisordersMember
- Americas Association of Sarcoidosis and Other DisordersMember
- Fellow
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
